Failure of gamma-interferon to decrease mortality from group B streptococcal sepsis in neonatal rats.

Area of Science:

• Neonatal immunology
• Infectious diseases
• Pharmacology

Background:

• Neonates exhibit impaired immune responses, including reduced leukocyte chemotaxis and deficient gamma-interferon (IFN-gamma) production.
• IFN-gamma plays a crucial role in enhancing neonatal leukocyte activation and mobility, suggesting a potential therapeutic target.

Purpose of the Study:

• To evaluate the efficacy of combining IFN-gamma with penicillin in improving survival rates for group B streptococcal (GBS) sepsis in a neonatal rat model.
• To compare the survival outcomes of rats treated with penicillin alone versus those treated with both IFN-gamma and penicillin.

Main Methods:

• Newborn rats were infected with group B streptococci.
• Rats were randomized into four groups: controls (serum albumin), IFN-gamma alone, penicillin alone, and IFN-gamma plus penicillin.
• Survival was assessed 120 hours postinfection.

Main Results:

• Survival rates were: controls 5%, IFN-gamma 4%, penicillin 23%, and IFN-gamma plus penicillin 10%.
• Statistical analysis indicated that penicillin monotherapy significantly improved survival compared to controls.
• No statistically significant difference in survival was observed between the penicillin group and the IFN-gamma plus penicillin group.

Conclusions:

• Penicillin monotherapy demonstrates efficacy in improving survival from GBS sepsis in neonatal rats.
• The addition of IFN-gamma to penicillin therapy did not provide a statistically significant survival benefit in this neonatal sepsis model.